Back grey_arrow_rt.gif
 
 
2010 NIAID Year in Review Includes Summary of HIV/AIDS Research Accomplishments
 
 
  The National Institute of Allergy and Infectious Diseases (NIAID) recently posted the 2010 NIAID Year in Review on the NIAID Web site. The review describes the Institute's scientific and programmatic accomplishments in FY 2010 and provides information on the budget for NIAID-supported initiatives and programs.
 
NIAID HIV/AIDS research activities detailed in the review include the following:
 
· New Directions in HIV Prevention: Description of NIAID-sponsored research aimed at preventing HIV infection, including approaches such as pre-exposure prophylaxis (PrEP), vaccines, and microbicides.
 
· Recent Successes in Developing an HIV Vaccine: Summaries of scientific findings resulting from NIAID-supported research into the development of an HIV vaccine.
 
· Reducing the Impact of HIV: Information about NIAID's support for research on eliminating persistent HIV viral reservoirs and extending PrEP research and on a NIAID initiative to respond to the HIV/AIDS epidemic in Washington DC.
 
Reducing the Transmission of HIV: Summary of results from the iPrEx study showing that a daily dose of emtricitabine and tenofovir (Truvada) reduced the risk of HIV acquisition among men who have sex with men (MSM).
 
 
 
  icon paper stack View Older Articles   Back to Top   www.natap.org